Replies to post #202968 on Biotech Values

[DewDiligence]

2Q16 Harvoni /Viekira /Zepatier in US/EU/Japan ($ M)

 
 US/EU/Japan  
 Harvoni  2434  82.1% 
 Viekira*  419  14.1% 
 Zepatier  112   3.8% 
  
 US  
 Harvoni  1474  88.1% 
 Viekira*   87   5.2% 
 Zepatier  112   6.7% 
  
 EU/Japan  
 Harvoni   960  74.3% 
 Viekira*  332  25.7%  
 Zepatier  n/a   n/a 

*Includes Viekira Pak, Viekirax, and Technivie.

[DewDiligence]

Viekira* Sales by Calendar Quarter ($ M)

  
          ---TOTAL--  ----US----  ---Ex-US-- 
 Quarter  Sales QoQ%  Sales QoQ%  Sales QoQ% 
    
   3Q16     378 -10%     76 -13%    302  -9% 
   2Q16     419  +1%     87 -30%    332 +15% 
   1Q16     414 -26%    125 -37%    289 -19% 
   4Q15     554 +18%    197 -19%    357 +57% 
   3Q15     469 +21%    242  +7%    227 +44% 
   2Q15     385 +67%    227 +64%    158 +70% 
   1Q15     231  --     138  --      93  --

*Includes Viekira Pak, Technivie and Viekirax.